15 results on '"Di Donna, Vincenzo"'
Search Results
2. Is levothyroxine requirement the same for tablet and soft gel formulations?
- Author
-
Di Donna, Vincenzo, Paragliola, Rosa Maria, de Waure, Chiara, Papi, Giampaolo, Pontecorvi, Alfredo, and Corsello, Salvatore Maria
- Published
- 2017
- Full Text
- View/download PDF
3. The Role of Adrenal Scintigraphy in the Diagnosis of Subclinical Cushing’s Syndrome and the Prediction of Post-surgical Hypoadrenalism
- Author
-
Ricciato, Maria Pia, Di Donna, Vincenzo, Perotti, Germano, Pontecorvi, Alfredo, Bellantone, Rocco, and Corsello, Salvatore M.
- Published
- 2014
- Full Text
- View/download PDF
4. The lymph nodes of the central compartment during autoimmune chronic thyroiditis: incidence and ultrasonographic aspects
- Author
-
Solivetti, Francesco Maria, Di Donna, Vincenzo, and Pontecorvi, Alfredo
- Published
- 2017
- Full Text
- View/download PDF
5. Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion
- Author
-
Mancini, Antonio, Leone, Erika, Festa, Roberto, Grande, Giuseppe, Di Donna, Vincenzo, De Marinis, Laura, Pontecorvi, Alfredo, Tacchino, Roberto Maria, Littarru, Gian Paolo, Silvestrini, Andrea, and Meucci, Elisabetta
- Published
- 2008
- Full Text
- View/download PDF
6. Inter- and Intraobserver Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification Systems: A Blinded Multicenter Study.
- Author
-
Persichetti, Agnese, Di Stasio, Enrico, Coccaro, Carmela, Graziano, Filomena, Bianchini, Antonio, Di Donna, Vincenzo, Corsello, Salvatore, Valle, Dario, Bizzarri, Giancarlo, Frasoldati, Andrea, Pontecorvi, Alfredo, Papini, Enrico, and Guglielmi, Rinaldo
- Subjects
CLASSIFICATION ,RADIOLOGISTS ,NODULAR disease ,THYROID gland ,INTER-observer reliability ,DIAGNOSTIC ultrasonic imaging ,ENDOCRINOLOGISTS - Abstract
Background: Single-center trials demonstrated moderate-substantial level of interobserver agreement in the evaluation of ultrasound (US) features of thyroid nodules. Multicenter studies on US agreement, however, are scanty, and data on intraobserver agreement are poor. Aim of the study was to assess inter- and intraobserver agreement between different thyroid centers and different specialists. Methods: A blinded analysis of 100 electronically recorded thyroid nodule US images was conducted in three large-volume thyroid centers by seven radiologists and endocrinologists. The evaluation was repeated after randomization 4 months later. The following US characteristics were evaluated: composition, echogenicity, margins, intranodular echogenic spots, vascularity, and shape. Thyroid nodules were also classified according to AACE/ACE/AME, EU-TIRADS, ATA, and ACR-TIRADS US classifications. Intra- and interobserver agreement was calculated using cross-tabulation expressed as mean Cohen's Kappa. Results: Interobserver agreement for US features: K-coefficient was 0.53 for composition, 0.47 for echogenicity, 0.46 for intranodular vascularity, and 0.33 for margins of the nodules. For echogenic foci, the K-coefficient was 0.47 for microcalcifications, 0.38 for macrocalcifications, 0.11 for the subcategory comet-tail artifacts, and 0.42 for shape. Operators resulted uncertain on hyperechoic foci definition in 16% of cases and described them as "hyperechoic foci of uncertain significance." Interobserver Cohen-K for US classification systems was 0.44 for AACE, 0.42 for ACR-TIRADS, 0.39 EU-TIRADS, and 0.34 for ATA. Intraobserver agreement: the K-coefficient for nodule US features was 0.62 for intranodular vascularity, 0.58 for composition, 0.60 for echogenicity, 0.54 for macrocalcifications, 0.55 for microcalcifications, 0.47 for comet tails, 0.39 for margins, and 0.35 for shape. Intraobserver Cohen-K for US classification systems was 0.54 for AACE, 0.49 for ACR-TIRADS, 0.38 for ATA, and 0.33 for EU-TIRADS. Conclusions: Intraobserver reproducibility for thyroid nodule US reporting and US classification systems appears fairly adequate, while the interobserver agreement between different centers is lower than that assessed in single-center trials. Reporting and rating ability of thyroid US examiners still appear not consistent. An unified lexicon of thyroid US features, a simplified method of classification, and a dedicated training in the description of thyroid US findings may increase the observers' agreement and the predictive value of US classification systems in real world practice. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Factors Predicting Time to TSH Normalization and Persistence of TSH Suppression After Total Thyroidectomy for Graves' Disease.
- Author
-
Paragliola, Rosa Maria, Di Donna, Vincenzo, Locantore, Pietro, Papi, Giampaolo, Pontecorvi, Alfredo, and Corsello, Salvatore Maria
- Subjects
THYROTROPIN ,THYROIDECTOMY ,GRAVES' disease ,HYPERTHYROIDISM ,THYROID hormones ,PITUITARY hormones ,LEVOTHYROXINE - Abstract
Hyperthyroidism related to Graves' disease is associated with a suppression of TSH values which may persist after surgery in spite of a LT
4 replacement therapy at non-TSH-suppressing doses. The aim of this retrospective study was to evaluate the time to TSH normalization in a group of patients who underwent total thyroidectomy for Graves' disease receiving a LT4 therapy dose regimen based on a previously published nomogram, and to identify possible correlations between the time to normalization of post-operative TSH values and preoperative clinical and biochemical parameters. 276 patients affected by Graves' disease who underwent surgery between 2010 and 2015, were retrospectively evaluated for clinical and biochemical parameters as well as post-surgical LT4 treatment regimen. Of the 276 subjects, 174 had initiated LT4 dosage corresponding to a previously published nomogram. 59 patients were excluded because their LT4 requirement (in mcg/kg/day) changed and deviated from the nomogram during the follow-up period, 15 patients were excluded because their TSH level was >4 mcU/ml during the first biochemical evaluation and 2 patients were excluded because they had low TSH levels potentially related to central hypothyroidism due to concomitant hypopituitarism. Therefore, 98 patients were included in our statistical analysis. TSH and FT4 were evaluated at the first post-operative assessment and during follow up until the normalization of TSH values was achieved, and then included in the analysis. During the first post-operative evaluation 2 months after surgery, 59/98 patients had TSH values in the normal range (0.4 to 4.0 mcU/ml), while 39/98 patients had a TSH value < 0.4 mcU/mL. The persistence of post-operative TSH levels < 0.4 mcU/ml was significantly correlated (p = 0.022) with longer duration of the disease. The value of anti-TSH receptor autoantibodies (TrAb) at the diagnosis of hyperthyroidism, significantly correlated (p = 0.002) with the time to TSH normalization in the group of patients with TSH < 0.4 mcU/ml at first control. This retrospective analysis confirms that in subjects who have undergone thyroidectomy for Graves' disease, time to normalization of TSH may be prolonged. Hence, the role of TSH as the "gold standard" to assess the appropriate LT4 replacement therapy regimen during the initial months following surgery may need to be reconsidered. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
8. CGF treatment of leg ulcers: a randomized controlled trial.
- Author
-
Amato, Bruno, Farina, Michele Angelo, Campisi, Silvana, Ciliberti, Marino, Di Donna, Vincenzo, Florio, Anna, Grasso, Antonino, Miranda, Rosario, Pompeo, Francesco, Farina, Eleonora, Serra, Raffaele, Cirocchi, Roberto, Calemma, Francesca, Rocca, Aldo, and Compagna, Rita
- Abstract
Background: Concentrated Growth Factors (CGF) is a concentration of second generation autologous growth factors compared to platelet rich plasma (PRP) and represents a multifactorial stimulation system that can be used for the management and treatment of chronic skin ulcers. Aim: The aim of this work is to evaluate the additional benefits of the CGF compared to the standard of dressing and its effects on the dynamics of the healing process. Methods: Autologous CGFs were obtained from 100 patients with chronic mixed ulcers (venous ulcers in patients with II stage claudication) of the lower limbs in a multicentric controlled randomized study. Results: The results showed a significant advantage in the use of CGF in association with cleansing and selective compression in the healing time and stabilization of mixed ulcers of the lower extremities. Conclusions: These results support the CGF’s clinical use for improving clinical outcomes in mixed ulcers of the legs. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Is levothyroxine requirement the same for tablet and soft gel formulations?
- Author
-
Di Donna, Vincenzo, Paragliola, Rosa Maria, de Waure, Chiara, Papi, Giampaolo, Pontecorvi, Alfredo, and Corsello, Salvatore Maria
- Published
- 2018
- Full Text
- View/download PDF
10. A New Strategy to Estimate Levothyroxine Requirement After Total Thyroidectomy for Benign Thyroid Disease.
- Author
-
Di Donna, Vincenzo, Santoro, Mario Giannotti, de Waure, Chiara, Ricciato, Maria Pia, Paragliola, Rosa Maria, Pontecorvi, Alfredo, and Corsello, Salvatore Maria
- Subjects
- *
LEVOTHYROXINE , *THYROIDECTOMY , *THYROID diseases , *TRIIODOTHYRONINE , *BODY weight , *BODY mass index , *LEAN body mass - Abstract
Background: The current approach for calculating the starting dose of levothyroxine (LT4) after total thyroidectomy is based on the patient's body weight (BW). The aim of the study was to identify the major predictive factors of LT4 requirement and to elaborate a new method to improve the accuracy of the LT4 starting dose after total thyroidectomy. Methods: The study consists of two parts. The first part consisted of the retrospective identification of 92 adult patients (retrospective cohort) who had undergone a total thyroidectomy for benign disease and who had begun LT4 treatment at a dose of 1.6 μg/kg/day. Adjustments to optimize the LT4 dose were then performed at the post-surgery follow-up on the basis of serum thyrotropin (TSH) levels. The results of this retrospective analysis were used to formulate a nomogram for a proper calculation of the LT4 starting dose that was then used prospectively in the second part of the study on 31 consecutive patients (prospective cohort). Results: At the first follow-up, 37 (40%) patients from the retrospective cohort were euthyroid. Univariate analysis indicated significant correlations between the optimal dose of LT4 and BW, body mass index (BMI), age, preoperative mean corpuscular volume, and free triiodothyronine (fT3). The optimal dose of LT4, analyzed for BMI and age, showed an inverse relationship with these two parameters, and ranged from 1.4 to 1.8 μg/kg/day. In the prospective cohort, the use of an age- and BMI-related nomogram improved the prediction of the optimal LT4 starting dose, with 68% of patients being euthyroid at the first follow-up compared to 41% of patients reported to have reached euthyroid state using the best strategy proposed in the literature. Conclusions: This study confirms that BW is not the only variable for predicting LT4 requirement, as it decreases with the increase in age and BMI, probably due to the relative decrease of lean body mass. A new correlation between optimal dose and presurgical levels of fT3 and mean corpuscular volume was observed. We propose an easy and more efficient method of calculating LT4 starting dose after total thyroidectomy for benign disease. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
11. Reply: Total antioxidant capacity after malabsorptive bariatric surgery
- Author
-
Mancini, Antonio, Leone, Erika, Di Donna, Vincenzo, Pontecorvi, Alfredo, Festa, Roberto, Littarru, Gian Paolo, Tacchino, Roberto, Silvestrini, Andrea, and Meucci, Elisabetta
- Published
- 2009
- Full Text
- View/download PDF
12. Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.
- Author
-
Martínez-Sánchez, Gregorio, Schwartz, Adriana, and Di Donna, Vincenzo
- Subjects
OZONE therapy ,VIRUS diseases ,SARS-CoV-2 ,COVID-19 ,CLINICAL trials - Abstract
(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-κB/Nrf2 pathways and IL-6/IL-1β expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-κB/Nrf2 balance and IL-6 and IL-1β expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
13. Hormonal regulation of total antioxidant capacity in seminal plasma.
- Author
-
Mancini A, Festa R, Silvestrini A, Nicolotti N, Di Donna V, La Torre G, Pontecorvi A, and Meucci E
- Subjects
- Adult, Humans, Hydrogen Peroxide metabolism, Infertility, Male etiology, Male, Oxidative Stress, Prolactin blood, Regression Analysis, Semen drug effects, Sperm Motility drug effects, Testosterone blood, Thyroid Hormones blood, Varicocele complications, Antioxidants analysis, Semen chemistry, Testosterone physiology, Thyroid Hormones physiology
- Abstract
Infertility is associated with oxidative stress, normally counterbalanced by different antioxidant systems. In order to explore the hormonal control of seminal plasma total antioxidant capacity (TAC) we evaluated TAC and hormone patterns in a group of unselected infertile patients and control subjects. One hundred and ten infertile patients (divided into 3 groups: inflammation, varicocele, and other etiologies) and 31 fertile men were examined, evaluating blood serum gonadotropins, testosterone, estradiol, free tri-iodothyronine, free tetraiodothyronine (FT4), thyrotropin, prolactin (PRL), seminal parameters, and TAC. TAC was measured using the H(2)O(2)-metmyoglobin system, which generates the spectroscopically detectable radical cation of the chromogenous compound 2,2(I)-azinobis (3-ethylbenzothiazoline-6-sulfonate). The "lag time" of its appearance is proportional to the antioxidant activity. Lag phase was significantly higher in varicocele vs controls, whereas it was lower in patients with inflammation vs varicocele or other kinds of infertility. The correlation analysis between hormones and seminal parameters showed an inverse correlation between PRL and sperm motility, and a direct correlation of TAC with PRL and FT4, but not with gonadotropins or gonadal steroids. Our data suggest that systemic hormones may play a role in regulating seminal antioxidant capacity. This is interesting also because some hormones, such as thyroid and pituitary hormones, are not usually tested in the first-level evaluation of male patients with fertility problems.
- Published
- 2009
- Full Text
- View/download PDF
14. [Pharmacologic therapy in failed thrombolysis: sequential infusion of tirofiban. Pilot study with 47 patients].
- Author
-
Vetrano A, Catanzaro M, Corsini F, Carotenuto R, Sorbo R, Izzo A, Di Donna V, De Lucia R, Chieffo C, and Corsini G
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Pilot Projects, Thrombolytic Therapy, Tirofiban, Treatment Failure, Fibrinolytic Agents administration & dosage, Tyrosine administration & dosage, Tyrosine analogs & derivatives
- Abstract
Glycoprotein IIb/IIIa inhibitors have been recently proposed as a bridge to rescue transluminal coronary angioplasty in ST elevation myocardial infarction patients in whom thrombolysis fails; but data in its feasibility, safety and efficacy are still limited. In 47 consecutive acute myocardial infarction patients in whom thrombolysis failed to achieve 90 minute reperfusion, tirofiban was given at full regimen. Our results have been compared with those obtained in a control group of 48 consecutive acute myocardial infarction patients admitted two years before, period in which tirofiban and rescue angioplasty were not available in our hospital. Our preliminary data suggest this approach is feasible and safe, with possible clinical benefit in this high-risk subgroup of patients.
- Published
- 2004
15. [Variations in QRS duration and axis with different sites and intervals of right ventricular pacing].
- Author
-
Mascia F, Fattore L, Viscusi M, Golino P, Di Donna V, and Ricciardiello V
- Subjects
- Adult, Aged, Aged, 80 and over, Electrocardiography, Female, Humans, Male, Middle Aged, Cardiac Pacing, Artificial methods, Heart Conduction System pathology, Heart Conduction System physiopathology, Heart Ventricles
- Abstract
Background: The aim of this study was to achieve left ventricular resynchronization by means of right ventricular pacing., Methods: We studied 12 patients (9 males, 3 females, mean age 61.7 +/- 19.5 years), with syncope, II degree atrioventricular block or ventricular arrhythmias, without intraventricular conduction disturbances. Single and dual site pacing, synchrony or at different delay, was made in the right ventricular, outflow tract from the apex, and midseptal areas., Results: In all patients we obtained the shortest QRS duration with synchrony or delayed bisite pacing (standard ventricular apex pacing 170 +/- 20 ms; bisite pacing 137 +/- 13 ms)., Conclusions: Our data demonstrate that appropriate right ventricular pacing can lead to left ventricular resynchronization.
- Published
- 2002
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.